CMS’s Final Medicare Part D Ruling Preserves Patient Access to Certain Cancer Drugs
Medicare Part D will continue to give patients access to certain cancer drugs, according Centers for Medicare and Medicaid Services’ (CMS’s) final ruling issued May 16, 2019. The final rule does not allow for utilization controls like step therapy and prior authorizations for patients who are already in an established treatment regimen; does not restrict drugs that have had certain price increases over a specified time period; and does not restrict new formulations of an existing protected class drug.
- Read more about CMS’s Final Medicare Part D Ruling Preserves Patient Access to Certain Cancer Drugs
- Add new comment
Lowy Appointed NCI Acting Director
Government service isn’t forever. Dynamic, transformative leaders enter and leave federally appointed positions for a variety of reasons and new appointments. Such was the case for the National Cancer Institute’s (NCI’s) former director Norman Sharpless, MD, who was appointed to head the U.S. Food and Drug Administration in April 2019 after Scott Gottlieb, MD, announced he would step down as of June 2019.
Oncology Drug Reference Sheet: Talazoparib
Initially approved in 2018, talazoparib (Talzenna®) capsules are indicated for the treatment of adult patients with deleterious or suspected deleterious germline breast cancer susceptibility gene HER2-negative locally advanced or metastatic breast cancer.
Commission on Cancer to Revise Standards for Cancer Program Accreditation
The Commission on Cancer (CoC), an organizational consortium of which ONS is a governing member, provides standards for cancer programs to follow to achieve a high level of continuous quality improvement. Last updated in 2016, the standards are currently undergoing analysis and revision, and CoC is seeking public comments until June 3, 2019.
- Read more about Commission on Cancer to Revise Standards for Cancer Program Accreditation
- Add new comment
Washington Healthcare Option; Dems Campaign Complication; States Sue Drug Manufacturers
Washington is the first state in the country to offer a public insurance option to its residents after Governor Jay Inslee signed the bill into law on May 13, 2019. Is it any coincidence that Inslee is also running for president? Coming from a traditionally “blue” state with a strong progressive legislature allowed this Democratic candidate to deliver on a particularly interesting policy.
- Read more about Washington Healthcare Option; Dems Campaign Complication; States Sue Drug Manufacturers
- Add new comment
U.S. Reps Introduce Legislation to Honor Cadet Nurses
It’s never too late to honor those who served the United States with great valor, especially during times of war and hardship. In April 2019, a group of federal legislators submitted a bipartisan, bicameral bill to honor cadet nurses who served during World War II. At the time, cadet nurses were not recognized with veteran distinctions, despite often serving in active warzones and filling a desperate need for medical care.
Young and Jones Introduce Nursing Where It’s Needed Act
In an increasingly rare show of bipartisan common ground, U.S. Senators Todd Young (R-IN) and Doug Jones (D-AL) introduced the Nursing Where It’s Needed (Nursing WIN) Act in April 2019. The bill would assist nurses in underserved areas of the country—particularly rural communities—that are facing nursing staff shortages.
CDC’s Triple-Negative Breast Cancer Virtual Program Helps Patients Understand the Disease
Unlike other types of breast cancer, a triple-negative diagnosis doesn’t have any of the common receptors found in other breast cancers, presenting potential treatment challenges to patients and providers. To assist patients with triple-negative breast cancer, the Centers for Disease Control and Prevention (CDC) created a new virtual program, allowing patients to consult and ask questions to a virtual coach in the comfort of their own homes.
- Read more about CDC’s Triple-Negative Breast Cancer Virtual Program Helps Patients Understand the Disease
- Add new comment
U.S. Rep Cummings Introduces Henrietta Lacks Enhancing Cancer Research Act
After recent a best-selling book-turned-movie detailed her story, Henrietta Lacks’ extraordinary impact on cancer research continues to become common knowledge to more people. However, many more are still unaware of how her story, struggle with cancer, and tumor cells changed the face of cancer care. For that reason, Representative Elijah Cummings (D-MD), along with a congressional delegation from both chambers, introduced legislation to both honor her role in history and improve access to medical research to traditionally underrepresented groups.
- Read more about U.S. Rep Cummings Introduces Henrietta Lacks Enhancing Cancer Research Act
- Add new comment
Commit to Protect and Care for Yourself During Oncology Nursing Month
May is a month of celebration as we look forward to graduations, Mother’s Day, National Nurses’ Day, and Oncology Nursing Month. Many of us will celebrate with small gifts or trinkets, continuing education events, or treats like special breakfasts, donuts, or pizza parties from our employers. How will you celebrate your role in a profession that the public continues to describe as the most trusted year after year? How will you continue to nurture and protect yourself as one of nearly 4 million national treasures?